Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Director departure
|
|
Zivo Bioscience, Inc. (ZIVO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/04/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/03/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/17/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...|
Docs:
|
"Form of Placement Agent Agreement",
"Form of Series A Common Warrant",
"Form of Series B Common Warrant",
"Form of Pre-Funded Warrant",
"Opinion of Fennemore Craig, P.C",
"Opinion of Honigman LLP",
"Form of Securities Purchase Agreement, by and between Zivo Biosciences, Inc. and the Investor",
"ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market" |
|
| 07/05/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/28/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 06/15/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/26/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/05/2023 |
4
| PAYNE JOHN BERNARD (President and CEO) has filed a Form 4 on Zivo Bioscience, Inc.|
Txns:
| Bought 390,000 warrants
@ $2.91, valued at
$1.1M
|
|
| 04/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Note",
"Warrant",
"Subscription Agreement",
"ZIVO Bioscience Receives $1 Million Bridge Financing BLOOMFIELD HILLS, Mich. – Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced a $1 million unsecured six-month loan from its Chairman, Chief Executive Officer, and President, John Payne. The loan carries 10% simple interest, may be prepaid without penalty, is extendable for an additional six months and includes warrants to purchase 390,000 shares of ZIVO common stock with a strike price of $2.91 per share. More information on the loan and warrants is available in ZIVO’s Form 8-K filed today with the SEC. ZIVO Bioscience intends to use the proceeds from this bridge financing for working capital ..." |
|
| 03/22/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 02/14/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/14/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
8-K
| Quarterly results |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/08/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/29/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 09/19/2022 |
4
| Maggiore Christopher D. (10% Owner) has filed a Form 4 on Zivo Bioscience, Inc.|
Txns:
| Bought 5,200 shares
@ $3.5281, valued at
$18.3k
Bought 2,000 shares
@ $3.5507, valued at
$7.1k
|
|
| 08/31/2022 |
4
| Marchiando Keith (10% Owner) has filed a Form 4 on Zivo Bioscience, Inc.|
Txns:
| Granted 62,000 options to buy
@ $3.94, valued at
$244.3k
|
|
| 08/23/2022 |
8-K
| Quarterly results |
|
|
|